« Management of Rheumatologic Immune-Related Adverse Events (Rh-irAEs) – An Overview of Immunosuppressive Therapies », Can Rheumatol Today, vol. 1, nᵒ 1, p. 34–39, avr. 2024, doi: 10.58931/crt.2024.1147.